NASDAQ:ANL Adlai Nortye (ANL) Stock Price, News & Analysis $15.74 +0.46 (+3.01%) Closing price 04:00 PM EasternExtended Trading$15.80 +0.06 (+0.39%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Adlai Nortye Stock (NASDAQ:ANL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Adlai Nortye alerts:Sign Up Key Stats Today's Range$15.13▼$15.9250-Day Range$9.20▼$15.9352-Week Range$0.88▼$17.25Volume156,607 shsAverage Volume166,034 shsMarket Capitalization$1.01 billionP/E RatioN/ADividend YieldN/APrice Target$29.50Consensus RatingModerate Buy Company Overview Adlai Nortye Ltd. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cancer and other serious diseases. The company’s research and development activities center on oncology and immuno-oncology, with the goal of addressing unmet needs in the treatment of solid tumors. Adlai Nortye’s lead candidate is buparlisib, also known as AN2025, an oral pan-class I phosphoinositide 3-kinase (PI3K) inhibitor being developed for oncology indications, including head and neck cancer. The company is also advancing additional investigational programs intended to target cancer-related biological pathways and potentially support combination treatment approaches. Founded in China, Adlai Nortye has pursued a global development strategy, conducting activities across China and the United States and seeking to develop its therapies for international markets. Its products remain investigational and are subject to clinical testing and regulatory review.AI Generated. May Contain Errors. Read More Adlai Nortye Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks43rd Percentile Overall ScoreANL MarketRank™: Adlai Nortye scored higher than 43% of companies evaluated by MarketBeat, and ranked 633rd out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.2 / 5Analyst RatingModerate Buy Consensus RatingAdlai Nortye has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on no strong buy ratings, 6 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialAdlai Nortye has a consensus price target of $29.50, representing about 87.4% upside from its current price of $15.74.Amount of Analyst CoverageAdlai Nortye has only been the subject of 4 research reports in the past 90 days.Read more about Adlai Nortye's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Adlai Nortye are expected to decrease in the coming year, from ($0.19) to ($0.34) per share. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted6.40% of the float of Adlai Nortye has been sold short.Short Interest Ratio / Days to CoverAdlai Nortye has a short interest ratio ("days to cover") of 26.81, which indicates bearish sentiment.Change versus previous monthShort interest in Adlai Nortye has recently decreased by 4.07%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAdlai Nortye does not currently pay a dividend.Dividend GrowthAdlai Nortye does not have a long track record of dividend growth. News and Social Media2.1 / 5News Sentiment0.34 News SentimentAdlai Nortye has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.80 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Adlai Nortye this week, compared to 2 articles on an average week. Company Ownership1.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Adlai Nortye insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $164,635.00 in company stock.Percentage Held by Institutions35.21% of the stock of Adlai Nortye is held by institutions.Read more about Adlai Nortye's insider trading history. Receive ANL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adlai Nortye and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ANL Stock News HeadlinesAdlai Nortye (NASDAQ:ANL) Cut to "Hold" at Wall Street ZenSeptember 12, 2026 | americanbankingnews.comAdlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Receives Average Recommendation of "Moderate Buy" from BrokeragesSeptember 10, 2026 | americanbankingnews.com$747 million in one quarter - with a 60% cash-flow targetThe company posted $747 million in net income last quarter and plans to return at least 60% of 2026 free cash flow to shareholders. Institutions control roughly 88% of shares, with BlackRock and Vanguard among the largest holders. A multi-year Palantir partnership is driving toward $500 million in run-rate savings by year-end 2026. Last quarter alone, the company returned $189 million to shareholders and repurchased 2.8 million shares.September 18 at 1:00 AM | Monument Traders Alliance (Ad)HC Wainwright Reaffirms "Buy" Rating for Adlai Nortye (NASDAQ:ANL)September 10, 2026 | americanbankingnews.comAdlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADCSeptember 8, 2026 | globenewswire.comMajor Insider Move Shakes Up Adlai Nortye’s Market NarrativeAugust 26, 2026 | tipranks.comAdlai Nortye Calls September Extraordinary Meeting to Authorize Major Share Issuance and Board ChangesAugust 26, 2026 | tipranks.comAdlai Nortye Group Ltd. Sponsored ADR Class AAugust 21, 2026 | cnn.comSee More Headlines ANL Stock Analysis - Frequently Asked Questions How have ANL shares performed this year? Adlai Nortye's stock was trading at $1.42 at the beginning of the year. Since then, ANL stock has increased by 1,008.5% and is now trading at $15.74. When did Adlai Nortye IPO? Adlai Nortye (ANL) raised $58 million in an IPO on Friday, September 29th 2023. The company issued 2,500,000 shares at $23.00 per share. Who are Adlai Nortye's major shareholders? Adlai Nortye's top institutional shareholders include Braidwell LP (1.99%), Boone Capital Management LLC (0.65%), Seven Fleet Capital Management LP (0.28%) and Tidal Investments LLC (0.07%). Insiders that own company stock include Xiaofeng Ye and Yang Lu. View institutional ownership trends. How do I buy shares of Adlai Nortye? Shares of ANL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Adlai Nortye own? Based on aggregate information from My MarketBeat watchlists, some other companies that Adlai Nortye investors own include PayPal (PYPL), Avino Silver & Gold Mines (ASM), nCino (NCNO), Construction Partners (ROAD), Taiwan Semiconductor Manufacturing (TSM), XPENG (XPEV) and Cogent Communications (CCOI). Company Calendar Today9/18/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 ANL's financial health is in the Green zone, according to TradeSmith. ANL has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:ANL Previous SymbolNASDAQ:ANL CIK1944552 Webwww.adlainortye.com Phone848-230-7430FaxN/AEmployees109Year Founded2004Price Target and Rating Average Price Target for Adlai Nortye$29.50 High Price Target$49.00 Low Price Target$20.00 Potential Upside/Downside+87.4%Consensus RatingModerate Buy Rating Score (0-4)2.71 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.04 Current Ratio9.55 Quick Ratio0.65 Sales & Book Value Annual Sales$5 million Price / Sales202.73 Cash FlowN/A Price / Cash FlowN/A Book Value($0.21) per share Price / Book-74.95Miscellaneous Outstanding Shares64,400,000Free FloatN/AMarket Cap$1.01 billion OptionableNot Optionable Beta1.04 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:ANL) was last updated on 9/18/2026 by MarketBeat.com Staff. From Our PartnersThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredElon Musk’s Hushed FCC Filing. Sept 25th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredIran War WARNING: Something Just ChangedA powerful Middle Eastern government is reportedly asking Trump for U.S. military help against Iran backed for...Banyan Hill Publishing | Sponsored$747 million in one quarter - with a 60% cash-flow targetThe company posted $747 million in net income last quarter and plans to return at least 60% of 2026 free cash ...Monument Traders Alliance | SponsoredWhy I went to Mount RushmoreA small miner just hit on gold in the hills surrounding Mount Rushmore, thanks to a breakthrough new technolog...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adlai Nortye Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Adlai Nortye With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
